NPI: 1730459025 · MONROVIA, CA 91016 · Clinical Medical Laboratory · NPI assigned 01/04/2012
Authorized official WILLIAMS, KIMBERLY controls 20+ related entities in our dataset. Read more
| Authorized Official | WILLIAMS, KIMBERLY (VP) |
| NPI Enumeration Date | 01/04/2012 |
Other providers sharing the same authorized official: WILLIAMS, KIMBERLY
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 94,416 | $2.25M |
| 2019 | 77,401 | $1.52M |
| 2020 | 62,054 | $1.39M |
| 2021 | 105,398 | $2.37M |
| 2022 | 87,071 | $1.74M |
| 2023 | 88,869 | $2.09M |
| 2024 | 72,538 | $1.69M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 233,441 | 217,396 | $4.39M |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 158,090 | 147,038 | $4.00M |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 39,085 | 38,171 | $2.93M |
| 88142 | 28,166 | 27,128 | $403K | |
| 88342 | 5,439 | 5,325 | $233K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 23,144 | 22,961 | $195K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 23,152 | 22,973 | $195K |
| 88141 | 26,295 | 26,139 | $190K | |
| 88307 | 1,279 | 1,279 | $141K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 10,403 | 10,026 | $105K |
| 88341 | 1,429 | 1,386 | $97K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 319 | 316 | $29K |
| 88304 | 1,483 | 1,443 | $23K | |
| 87625 | 894 | 890 | $21K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 2,075 | 2,022 | $18K |
| 88312 | 1,327 | 1,293 | $17K | |
| 88321 | 343 | 322 | $17K | |
| 88112 | 616 | 602 | $8K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 1,680 | 1,678 | $5K |
| 80053 | Comprehensive metabolic panel | 3,103 | 3,097 | $4K |
| 80061 | Lipid panel | 2,700 | 2,699 | $3K |
| 84443 | Thyroid stimulating hormone (TSH) | 2,197 | 2,197 | $3K |
| 87529 | 1,148 | 1,147 | $3K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 1,360 | 1,360 | $3K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2,692 | 2,687 | $3K |
| 88360 | 13 | 13 | $3K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 818 | 815 | $2K |
| 83036 | Hemoglobin; glycosylated (A1C) | 2,439 | 2,439 | $2K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 65 | 63 | $769.65 |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 241 | 222 | $746.25 |
| 86592 | 673 | 672 | $703.82 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 295 | 291 | $578.49 |
| 99199 | Unlisted special service, procedure or report | 69 | 68 | $537.50 |
| 87086 | Culture, bacterial; quantitative colony count, urine | 707 | 700 | $497.66 |
| 84439 | 1,072 | 1,072 | $401.40 | |
| 80074 | 95 | 95 | $274.87 | |
| 86480 | 106 | 106 | $267.14 | |
| 82607 | 567 | 567 | $232.39 | |
| 86803 | 562 | 560 | $227.50 | |
| 82728 | 265 | 265 | $225.15 | |
| 88164 | 1,714 | 1,712 | $200.87 | |
| 82746 | 418 | 418 | $176.75 | |
| G0145 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision | 145 | 145 | $155.39 |
| 88344 | 13 | 12 | $147.71 | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 457 | 232 | $146.22 |
| 83550 | 258 | 258 | $142.75 | |
| 81001 | 616 | 615 | $140.58 | |
| 82274 | 183 | 183 | $128.34 | |
| 83540 | 270 | 270 | $122.25 | |
| 82043 | 480 | 480 | $99.42 | |
| 82570 | 421 | 421 | $90.11 | |
| 87088 | 210 | 208 | $70.98 | |
| 87186 | 182 | 180 | $63.15 | |
| 80081 | 29 | 29 | $51.99 | |
| 83013 | 22 | 22 | $46.78 | |
| 84702 | 47 | 47 | $31.38 | |
| 81003 | 134 | 134 | $31.14 | |
| 86696 | 60 | 60 | $26.88 | |
| 84153 | 139 | 139 | $25.56 | |
| 86695 | 60 | 60 | $18.32 | |
| 85652 | 118 | 118 | $15.80 | |
| 86140 | 59 | 59 | $15.47 | |
| 85027 | 204 | 203 | $14.88 | |
| 87077 | 56 | 56 | $11.80 | |
| 82950 | 32 | 32 | $9.87 | |
| 83655 | 57 | 57 | $9.28 | |
| 87081 | 14 | 14 | $9.20 | |
| 87340 | 47 | 47 | $7.18 | |
| 83735 | 12 | 12 | $4.65 | |
| 36415 | Collection of venous blood by venipuncture | 278 | 278 | $0.00 |
| 84436 | 16 | 16 | $0.00 | |
| 86376 | 53 | 40 | $0.00 | |
| 86160 | 15 | 13 | $0.00 | |
| 87522 | Neg quan hep c or qual rna | 32 | 31 | $0.00 |
| 86225 | 17 | 14 | $0.00 | |
| 83002 | 12 | 12 | $0.00 | |
| 86038 | 63 | 60 | $0.00 | |
| 84550 | 57 | 57 | $0.00 | |
| 86256 | 45 | 32 | $0.00 | |
| 88147 | 179 | 179 | $0.00 | |
| 86200 | 15 | 15 | $0.00 | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 200 | 162 | $0.00 |
| 86235 | 38 | 26 | $0.00 | |
| 82785 | 48 | 48 | $0.00 | |
| 86003 | 110 | 106 | $0.00 | |
| 83516 | 143 | 119 | $0.00 | |
| 84450 | 27 | 27 | $0.00 | |
| 84482 | 12 | 12 | $0.00 | |
| 82565 | 14 | 14 | $0.00 | |
| 82977 | 14 | 14 | $0.00 | |
| 86431 | 30 | 30 | $0.00 | |
| 85610 | 12 | 12 | $0.00 | |
| 84520 | 13 | 13 | $0.00 |